Name: ACR 2025 Highlights: Day 3 by The Lupus Forum
Duration: 4 min 4 s
Description: Join Professor Ed Vital as he summarises his top abstracts, posters, and presentations from Day 3 of ACR 2025 (Tuesday, October 28th).

Join Professors Ed Vital and Michelle Kahlenberg as they delve into the role of the cGAS pathway in systemic lupus erythematosus (SLE). This engaging discussion covers the pathway’s relevance in disease, recent clinical trial updates on cGAS inhibitors, and their potential role in the future treatment of SLE.

cGAS Podcast

Join Professors Ed Vital and Maria Dall’Era, and Doctor Guillermo J. Pons-Estel for an expert-led discussion focusing on the latest ACR 2025 SLE Guidelines. This podcast provides an overview of the latest treatment recommendations, as well as ungraded, consensus-based good practice statements that are applicable to children and adults with SLE.

If you are interested in the paper discussed, head on over to the Lupus Forum today! Download our latest slide decks and stay up to date with our monthly podcasts, all through this free independent resource: https://lupus-forum.com/ 


Discussing Lupus: 2025 ACR Guideline for the Treatment of SLE

Join Professor Brad Rovin for an expert-led discussion focused on emerging therapies and renal outcomes in LN. This podcast will provide an overview of the effect of long-term voclosporin treatment on renal histology in patients with active LN with repeat renal biopsies, and explore how BCMA-targeted CAR T-cell therapy can effectively induce disease remission in refractory LN. 

If you are interested in the papers discussed, head on over to the Lupus Forum today! 

Download our latest slide decks and stay up to date with our monthly podcasts, all through this free independent resource: https://lupus-forum.com/

Discussing Lupus: Emerging therapies and renal outcomes in LN

Professor Eric Morand and Professor Rangi Kandane-Rathnayake discuss the therapeutic strategies and emerging treatments in SLE and LN. This podcast provides a valuable framework for guiding therapeutic decisions for rare SLE manifestations where the available recommendations might be insufficient or inapplicable. The efficacy, PK and safety of iscalimab versus placebo as add-on to SoC therapy in patients with biopsy-proven active proliferative LN is also reported.

If you are interested in the papers discussed, head on over to the Lupus Forum today! Download our latest slide decks and stay up to date with our monthly podcasts, all through this free independent resource: https://lupus-forum.com/

Discussing Lupus: Therapeutic strategies and emerging treatments in SLE and LN

Join Professors Ed Vital and Maria Dall'Era as they preview what they are most looking forward to this ACR, introducing some of the top abstracts and posters we’ve chosen so that you can better plan your time at what will be a busy and exciting congress.

Lupus at ACR 2025: Preview Podcast

Join Professor Ed Vital as he summarises his top abstracts, posters, and presentations from Day 1 of ACR 2025 (Sunday, October 26th).

ACR 2025 Highlights: Day 1

Join Professor Ed Vital as he summarises his top abstracts, posters, and presentations from Day 2 of ACR 2025 (Monday, October 27th).

ACR 2025 Highlights: Day 2

Join Professor Ed Vital as he summarises his top abstracts, posters, and presentations from Day 3 of ACR 2025 (Tuesday, October 28th).

ACR 2025 Highlights: Day 3

Join Professor Ed Vital as he summarises his top abstracts, posters, and presentations from Day 4 of ACR 2025 (Wednesday, October 29th).

ACR 2025 Highlights: Day 4

Join Professor Chris Edwards and Doctor Alice Mason as they discuss EULAR recommendations for a core dataset in SLE and efficacy and safety of upadacitinib as a monotherapy or combination with elsubrutinib for SLE. This podcast provides a valuable framework for guiding therapeutic decisions in SLE, and also supporting clinical care, translational/observation research.

If you are interested in the papers discussed, head on over to the Lupus Forum today! Download our latest slide decks and stay up to date with our monthly podcasts, all through this free independent resource: https://lupus-forum.com/

Discussing Lupus: EULAR recommendations and long-term efficacy/safety of JAKis or BTKs

Welcome to the Lupus Forum. The Lupus Forum is an educational website developed under the auspices of the University of Leeds and is dedicated to the dissemination of the latest developments in the field of lupus. It provides continuing medical education to clinicians around the globe to facilitate greater understanding of lupus, its treatments, and clinical practice.

ACR 2025 Highlights: Day 3

The Lupus Forum

Related tracks